Skip to the page

Data / Form D filings / NJ BIO, Inc.

NJ BIO, Inc.: Form D filing

NJ BIO, Inc., a company in Princeton, NJ, filed a Form D with the SEC in 2023. The latest, on March 9, 2023, reports $5.6 million sold of a $7.8 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
350 CARTER ROAD, Princeton, NJ, 08540
Phone
(215) 485-2584
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1968755

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 9, 2023New notice$7,836,033$5,621,204$2,214,82910Feb 22, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
STEVEN KLOSKDirector
ANJANISH GONDALIADirector
RONALD GOLDDirector
PRIYASHRI NAYAKDirector
CHETAN JAINDirector
NARESHKUMAR JAINExecutive Officer, Director

Other companies in New Jersey that filed recently

Every Form D from the week of Mar 6, 2023 · All recent filings in New Jersey · All recent Other filings

Read from SEC EDGAR. Amount sold is what NJ BIO, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.